It has been proposed that immunization with these epitopes activates Qa-1-restricted CD8+ Treg cells that target the pathogenic autoimmune cells to ameliorate autoimmune diseases (e.g. EAE, CIA, and T1D)19, 21, 25, 40, 41. Here, CD8A is linked to type 1 diabetes mellitus.